Samil Pharmaceutical Co.,Ltd (KRX: 000520)

Market Cap	272.59B
Revenue (ttm)	212.42B
Net Income (ttm)	-1.17B
Shares Out	21.23M
EPS (ttm)	-71.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	170,984
Open	13,020
Previous Close	13,100
Day's Range	12,670 - 13,130
52-Week Range	6,170 - 19,500
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About Samil Pharmaceutical Co.,Ltd

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Se...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 585
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000520